European growth capital 29 June 2026 9 min read
Read together, Dan Wang's Breakneck and Ezra Klein and Derek Thompson's Abundance ask why rich societies have become so poor at turning ambition into physical reality — and what boards, investors and Europe should take from the answer.
Read essay Healthcare Innovation 13 June 2026 5 min read
A model performing well in a study is not the same as an organisation being ready to deploy it safely. Healthcare AI is an operating-model change — and that gap is the board's to govern.
Read essay European growth capital 11 June 2026 5 min read
The Mansion House Accord is welcome, but a pension-allocation target is not a capital-markets strategy. The test is whether high-quality UK companies can actually access the capital to scale.
Read essay Talent, opportunity and society 9 June 2026 6 min read
Young people are often called impatient or unrealistic. The polling suggests something else — a rational reading of housing, work and security. For boards, that is a workforce-strategy question, not a social footnote.
Read essay Private-company governance 26 April 2026 6 min read
Private-company governance sits closer to ownership, capital, founders and execution. The board has to be designed for that reality.
Read essay Chairmanship and board effectiveness 24 April 2026 5 min read
The chair-CEO relationship works best when support, challenge, trust and escalation are made explicit.
Read essay AI in the boardroom 22 April 2026 6 min read
Boards do not need to become machine-learning teams, but they do need sharper questions about data, accountability, controls and resilience.
Read essay Healthcare Innovation 19 April 2026 7 min read
MedTech boards govern across overlapping systems: clinical evidence, regulation, reimbursement, adoption, product risk and commercial scale.
Read essay European growth capital 17 April 2026 5 min read
Capital matters, but so do boards capable of helping companies scale through complexity, regulation and international expansion.
Read essay